Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Total Debt (2020)

Caribou Biosciences (CRBU) has disclosed Total Debt for 1 consecutive years, with $924000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Total Debt changed N/A to $924000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $924000.0, a N/A change, with the full-year FY2020 number at $924000.0, changed N/A from a year prior.
  • Total Debt was $924000.0 for Q4 2020 at Caribou Biosciences.
  • In the past five years, Total Debt ranged from a high of $924000.0 in Q4 2020 to a low of $924000.0 in Q4 2020.